Sarcopenia is a geriatric condition featured by a progressive loss of muscle mass and
function and associated with various adverse health outcomes. In this review, we aimed to …

Sarcopenia is the loss of muscle strength, mass, and function, which is often exacerbated by
chronic comorbidities including cardiovascular diseases, chronic kidney disease, and …

Sarcopenia indicates a loss of skeletal muscle mass, a condition that leads to a decline in
physical performance. In 2018, the European Working Group on Sarcopenia in Older People …

To date, sarcopenia is considered a patient-specific imaging biomarker able to predict
clinical outcomes. Several imaging modalities, including dual-energy X-ray absorptiometry …

The term sarcopenia, derived from the Greek words sarx for flesh and penia for loss, was first
introduced by Rosenberg 1 in 1989 to describe the loss of muscle mass that accompanies …

The core function of a multidisciplinary team (MDT) is to bring together a group of healthcare
professionals from different fields in order to determine patients' treatment plan. Most of head …

Purpose Previous studies have shown an association of sarcopenia with adverse short-and
long-term outcomes in multiple gastrointestinal cancer types. We aimed to investigate the …

Sarcopenia, an age-related decline in skeletal muscle mass and function, dramatically
affects the quality of life. Although there is a consensus that sarcopenia is a multifactorial …

Background The evidence that body composition parameters influence multiple cancer
outcomes is rapidly expanding. Excess adiposity deposits in muscle tissue, termed …

Importance Systemic inflammation and sarcopenia are easily evaluated, predict mortality in
many cancers, and are potentially modifiable. The combination of inflammation and …